November 4, 2025

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring a 34.90% Potential Upside in the Medical Device Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a notable player in the healthcare sector, specializing in medical devices. With a market capitalization of approximately $894.98 million, this U.S.-based company is..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking the 99.89% Potential Upside in Biotechnology

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing the attention of investors with a staggering potential upside of 99.89%. With a market capitalization of $1.14..

Bausch Health Companies Inc. (BHC) Stock Analysis: Understanding the Potential Behind a 5.24% Upside

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, offers a compelling investment narrative for those interested in the specialty and generic drug manufacturing industry. Headquartered..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Navigating a 28% Potential Upside in the Biotech Sector

MoonLake Immunotherapeutics (MLTX), a Swiss-based biotechnology firm, is capturing the interest of investors with its innovative approach to treating inflammatory skin and joint diseases. Specializing in the development of Sonelokimab,..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling a 16.69% Potential Upside in the Medical Devices Sector

For investors searching for opportunities in the healthcare sector, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents a compelling case with its promising 16.69% potential upside. This Costa Rica-based company, specializing..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 2.98% Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a significant player in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $2.33 billion, Premier provides a..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating the Healthcare Frontier with a 14.56% Upside Potential

Investors seeking to delve into the evolving landscape of virtual healthcare might find Teladoc Health, Inc. (NYSE: TDOC) to be a compelling contender. This healthcare information services company is a..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Healthcare Giant’s 31.52% Potential Downside

Investors with an eye on the healthcare sector may find GRAIL, Inc. (GRAL) an intriguing, albeit challenging, prospect. As a leader in the diagnostics and research industry, GRAIL’s mission to..

CONMED Corporation (CNMD) Stock Analysis: A Medical Device Player with 35.98% Potential Upside

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity for those interested in the medical technology space. With a..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 6.52% Potential Upside in the CNS Market

Supernus Pharmaceuticals, Inc. (SUPN), a key player in the healthcare sector specializing in the development and commercialization of treatments for central nervous system (CNS) disorders, offers investors a unique opportunity..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating the DNA Frontier with a 24.89% Upside

Twist Bioscience Corporation (NASDAQ: TWST) is at the forefront of the synthetic biology revolution, leveraging its expertise in synthetic DNA-based products to transform the healthcare and research landscapes. As a..

MannKind Corporation (MNKD): Investor Outlook and 89.32% Potential Upside in Biotech

MannKind Corporation (NASDAQ: MNKD), a notable player in the biotechnology landscape, is making waves with its innovative solutions in the healthcare sector. Specializing in therapeutic products for endocrine and orphan..

Select Medical Holdings Corp (SEM): Investor Outlook on a 35% Potential Upside with Strong Buy Ratings

As investors scour the healthcare sector for promising opportunities, Select Medical Holdings Corporation (NYSE: SEM) emerges as an intriguing candidate. With a market capitalization of $1.66 billion, this U.S.-based company..

ARS Pharmaceuticals (SPRY) Stock Analysis: Unpacking the Massive 263% Upside Potential

Investors eyeing the biotechnology sector might want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a company making significant strides in the healthcare industry. With a market..

Guardian Pharmacy Services, Inc. (GRDN): Investor Outlook with a 14.8% Revenue Growth Trajectory

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a significant player in the healthcare sector, specializes in providing technology-enabled pharmacy services to long-term healthcare facilities across the United States. With a market..

Phreesia, Inc. (PHR): Investor Outlook Highlights 48.7% Potential Upside

Phreesia, Inc. (NYSE: PHR), a leader in healthcare information services, is capturing investor attention with a promising potential upside of 48.7%. Specializing in a SaaS-based platform, Phreesia provides critical software..

Schrodinger, Inc. (SDGR) Investor Outlook: Analyzing a 31% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR) is making waves in the healthcare sector with its innovative approach to drug development and molecular discovery. With a market capitalization of $1.51 billion, this New..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Is a 31% Upside Within Reach for This Bioelectric Medicine Pioneer?

Pulse Biosciences, Inc. (NASDAQ: PLSE), a trailblazer in the field of bioelectric medicine, is making waves in the healthcare sector with its cutting-edge technology and innovative treatment platforms. Headquartered in..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A 13.76% Potential Upside Awaits Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stands out in the healthcare sector, especially within the niche of specialty and generic drug manufacturing. The company, headquartered in Baudette, Minnesota, is gaining attention..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: A 76% Upside with Strong Buy Ratings in the Biotech Arena

For investors exploring opportunities within the healthcare sector, particularly in biotechnology, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a compelling case. With a market capitalization standing at $2.62 billion, Apellis is..

Search

Funds

November 4, 2025

Search

Funds

November 4, 2025

FTSE 100

Funds